Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00925080 · ClinicalTrials.gov registry record
Pivotal Study of the Intravenous Blood Glucose (IVBG) System, In-Clinic Setting
A clinical trial, sponsored by DexCom.
- Completed
- Registry status
- 50
- Enrollment target
NCT00925080 is a clinical trial that has completed, run by DexCom. The registered enrollment target is 50 participants.
The verdict
NCT00925080 has completed, sponsored by DexCom.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate safety and accuracy of the IVBG System (the "System") when used to track blood glucose in insulin treated subjects with diabetes mellitus in an in-clinic setting for up to 72 hours (per subject). Reference blood glucose measurements will be collected across the entire reportable range of the System (e.g., 40 400 mg/dL) with adequate sampling at the upper and lower ends of this range. IVBG System accuracy will primarily be assessed relative to ISO 15197 criteria (i.e., within ±15 mg/dL at YSI glucose levels \< 75 mg/dL, and within ±20% at YSI glucose levels \>75 mg/dL).
Interventions
- DEVICE IVBG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2009-06 |
| Est. Completion | 2009-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00925080
The ClinicalTrials.gov registry entry for NCT00925080 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is DexCom, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which IVBG is the first listed.
NCT00925080 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00925080 about?
NCT00925080 is a clinical study titled "Pivotal Study of the Intravenous Blood Glucose (IVBG) System, In-Clinic Setting". The purpose of this study is to evaluate safety and accuracy of the IVBG System (the "System") when used to track blood glucose in insulin treated subjects with diabetes mellitus in an in-clinic setting for up to 72 hours (per subject). Reference blood glucose measurements will be collected across t...
What is the current status of trial NCT00925080?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2009-06. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00925080?
The interventions under investigation include: IVBG (DEVICE).
Who is sponsoring clinical trial NCT00925080?
This trial is sponsored by DexCom, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.